Single-voxel proton MR spectroscopy in toluene abuse

Magnetic Resonance Imaging

Volumn 21, Issue 7, 2003, Pages 777-785

  Aydin, Kubilay ^a   Sencer, Serra ^a   Ogel, Kultekin ^b   Genchellac, Hakan ^a   Demir, Turkay ^c   Minareci, Ozenc ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Bakirkoy State Hos Neu/Psych Dis   (Turkey)

^c NONE   (Turkey)

Author keywords

Abuse; Encephalopathy; Magnetic Resonance; Spectroscopy; Toluene

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID; TOLUENE;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DRUG DEPENDENCE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THALAMUS;

ILEX COOKII;

EID: 0141889060     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(03)00175-9     Document Type: Article

References (43)

1. Ashton CH. Solvent abuse. Br Med J 1990;20:135-6.
2. Watson JM. Solvent abuse: Presentation and clinical diagnosis. Human Toxicol 1982;1:249-56.
3. Knox JW, Nelson JR. Permanent encephalopathy from toluene inhalation. N Engl J Med 1966;275:1494-6.
4. King MD, Day RE, Oliver JS, Lush M, Watson JM. Solvent encephalopathy. Br Med J 1981;283:663-5.
5. Grabski DA. Toluene sniffing producing cerebellar degenaration. Am J Psychiat 1961;118:461-2.
6. Boor JW, Hutrig HI. Permanent cerebellar ataxia after exposure to toluene. Ann Neurol 1977;2:440-2.
7. King MD. Neurologic sequelae of toluene abuse. Human Toxicol 1982;1:281-7.
8. Lazar RB, Ho SU, Melen O, Daghestani AN. Multifocal central nervous system damage caused by toluene abuse. Neurology 1983; 33:1337-40.
9. Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol Scand 1983;67:319-29.
10. Byme A, Kirby B, Zibin T, Ensminger S. Psychiatric and neurologic effects of chronic solvent abuse. Can J Psychiatry 1991;36:735-8.
11. Ron MA. Volatile substance abuse: A review of possible long-term neurologic, intellectual and psychiatric sequelae. Ann Neurol 1986; 148:235-46.
12. Streicher HZ, Gabow PA, Moss AH, Kono D, Kaehny WD. Syndromes of toluene sniffing in adults. Ann Intern Med 1981;94:758-62.
13. Zur J, Yule W. Chronic solvent abuse. 1. Cognitive sequelae. Child Care Health Dev 1990;16:1-20.
14. Uitti RJ, Snow BJ, Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994;35:616-9.
15. Johnson AC, Canlon B. Progressive hair cell loss induced by toluene exposure. Hear Res 1994;75:201-8.
16. Yamanouchi N, Okada S, Kodama K, et al. White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 1995;16:1643-9.
17. Caldemeyer KS, Pascuzzi RM, Moran CC, Smith RR. Toluene abuse causing reduced signal intensity in the brain. AJR 1993;161:1259-61.
18. Xiong L, Matthes JL, Jinkins JR. MR Imaging of "spray heads:" Toluene abuse via aerosol paint inhalation. AJNR Am J Neuroradiol 1992;14:1195-9.
19. Ashikaga R, Araki Y, Miura K, Ishida O. Cranial MRI in chronic thinner intoxication. Neuroradiology 1995;37:443-4.
20. Aydin K, Sencer S, Demir T, Ogel K, Tunaci A, Minareci O. Cranial MR findings of toluene abuse by inhalation. Am J Neuroraiol AJNR 2002;23:1173-9.
21. Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impaiment and MRI abnormalities associated with chronic solvent abuse. Clin Toxicol 2002;40:21-34.
22. Rosenberg NL, Kleinschmidt BK, Davis KA, Dreisbach JN, Hormes JT, Filley CM. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988;23:611-4.
23. Jayasundar R, Raghunatuan P. Evidence of left-right asymmetries in the proton MRS of brain in normal volunteers. Magn Reson Imaging 1997;15:223-34.
24. Huang J, Asaeda N, Takeuchi Y, Shibata E, Hisanaga N, Ono Y, Kato K. Dose dependent effects of chronic exposure to toluene on neuronal and glial cell marker proteins in the central nervous system of rats. Br J Ind Med 1992;49:282-6.
25. Huang J, Kato K, Shibata E, Asaeda N, Takeuchi Y. Nerve-specific marker proteins as indicators of organic solvent neurotoxicity. Envr Research 1993;63:82-7.
26. Gotohda T, Tokunaga I, Kubo S, Morita K, Kitamura O, Eguchi A. Effect of toluene inhalation on astrocytes and neurotrophic factor in rat brain. Forensic Sci Int 2000;113:233-8.
27. Miller BL. A review of chemical issues in H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52.
28. Simmons M, Frondoza C, Coyle J. Immunocytochemical localization of N-acteyl aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45.
29. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, Bruck W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619-27.
30. Rajanayagam V, Grad J, Krivit W, et al. Proton MR spectroscopy of childhood adrenoleukodystrophy. AJNR Am J Neuroradiol 1996;17:1013-24.
31. Kimura H, Fujii Y, Itoh S, et al. Metabolic alterations in neonate and infant brain during development: evaluation with proton MR spectroscopy. Radiology 1995;194:483-9.
32. Eschobar A, Aruffo C. Chronic Thinner intoxication: clinicopathologic report of a human case. J Neurol Neurosurg Psychiatry 1980; 43:986-94.
33. Ladefoged O, Strange P, Moller A, et al. Irreversible effects in rats of toluene (inhalation) exposure for six months. Pharmacol Toxicol 1991;68:384-90.
34. Mader I, Roser W, Kappos L, Hagberg G, Seelig J, Radue EW, Steinbrich W. Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. AJNR Am J Neuroradiol 2000;21:1220-7.
35. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
36. Noda S, Yamanouch N, Okada S, Kodama K, Murakami A, Sekina H, Sakamoto T, Komatsu N, Sato T, Ikehira H, Morita F. Proton MR spectroscopy in Solvent Abuse. Ann Ny Acad Sci 1996;805:441-4.
37. Stengard K, Tham R, O'Connor WT, Höglund G, Ungerstedt U. Acute toluene exposure increases extracellular GABA in the cerebellum of rat: A microdialysis study. Pharmacol Toxicol 1993;315-8.
38. Von Euler G, Ögren S, Eneroth P, Fuxe K, Gustafsson J. Persistent effects of 80ppm toluene on dopamine regulated locomotory activity and prolactin secretion in the male rat. Neurotoxicology 1994;15:621-4.
39. Stengard K. Effects of toluene inhalation on extracellular striatal acetylcholine release studied with microdialysis. Pharmacol Toxicol 1994;75:115-8.
40. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001;57:1248-52.
41. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurologic disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000;48:893-901.
42. Gospe SM, Calaban MJ. Central nervous system distribution of inhaled toluene. Fundam Appl Toxicol 1988;11:540-5.
43. Slomianka L, Edelfors S, Ravn-Jonsen A, Rungby J, Danscher G, West MJ. The effect of low-level toluene exposure on the developing hippocampal region of the rat: histologic evidence and volumetric findings. Toxicology 1990;62:189-202.